Tirzepatide not working for you? Here's what's actually going on

You're three weeks in and the scale hasn't moved (this is almost always the dose

Picture this: your Mounjaro pen arrives in a plain box via DPD, you track it on your phone, you start injecting on schedule) and then very little happens. The most common reason is straightforward. The first pen (2.5mg) is a tolerability dose. Its job is to give your gut, your pancreas, and your appetite signalling time to acclimatise to a dual GIP and GLP-1 receptor agonist. Expecting dramatic weight loss at 2.5mg is a bit like expecting a car to reach motorway speed in first gear.

Tirzepatide works by slowing gastric emptying and increasing satiety signals, but both effects build across the titration ladder. How long tirzepatide takes to work depends heavily on which dose you're currently at, and the clinical evidence (including the SURMOUNT-1 trial published in the New England Journal of Medicine) followed participants over 72 weeks at target doses, not at the starter level. If you're still in the early titration phase, measured patience is clinically appropriate.

That said, if nausea or GI side effects have forced you to stay at a lower dose longer than planned, that matters too. Your prescriber can review whether staying at the current dose a little longer, or moving up more gradually, is the right call for you.

When tirzepatide seems to stop working after it started

A different scenario: tirzepatide was working, appetite dropped, weight moved, and then progress slowed or stopped. This is common and well-documented. There are several overlapping explanations.

First, your body's energy expenditure adapts as weight falls. A smaller body burns fewer calories at rest, so the deficit created by reduced appetite naturally narrows over time. This isn't a sign that the medicine has failed; it's basic physiology. The NHS tirzepatide guidance reinforces that the medicine works alongside a reduced-calorie diet and increased activity, neither element is optional background noise.

Second, what you eat matters as much as how much. Tirzepatide reduces appetite for volume, but calorie-dense foods (alcohol, ultra-processed snacks, liquid calories) can quietly replace what the suppressed appetite removes. People sometimes find they're eating much less food but not fewer calories.

Third, sleep debt, chronic stress, and cortisol can blunt weight loss even when medication and diet are on track. These are not excuses, they're physiology. For a detailed look at the most common reasons progress slows, this page on weight loss stalling on tirzepatide goes through each factor specifically.

Factors that can genuinely interfere with tirzepatide's effect

Some things directly reduce how well tirzepatide works, and they're worth ruling out before concluding the medicine isn't right for you.

Oral contraceptives are one example. The NHS England guidance on weight-management injections notes that tirzepatide can reduce absorption of the pill, particularly during the first four weeks of treatment and for four weeks after each dose increase, a non-oral contraceptive method should be added during those windows. This is a contraception safety point, but it also illustrates that tirzepatide changes how other things are absorbed.

Other medications (corticosteroids, some antidepressants, antipsychotics, and certain blood pressure drugs) can independently promote weight retention or oppose weight loss. If your prescription list has changed recently, that's worth flagging to your prescriber when you discuss Mounjaro not working.

Thyroid function is another variable. Undiagnosed or under-treated hypothyroidism makes weight loss measurably harder. If it hasn't been checked recently, ask your GP or the prescribing team.

Finally, injection technique matters more than people expect. Injecting into the same site repeatedly creates scar tissue that reduces absorption. Rotating between abdomen, thigh, and upper arm (as the patient information leaflet advises) keeps absorption consistent. Questions about your specific situation are something our clinical team fields regularly.

When to treat a plateau as a clinical signal, not a personal failure

If you've been at the highest dose you can tolerate for several months and weight loss has genuinely stopped, NICE guidance (TA1026) notes that continuing should be reviewed if less than 5% of body weight has been lost by that point. That review is a clinical process, not a verdict. It might lead to a dose change, an investigation into another cause, or a discussion about combining approaches.

It's worth understanding the private cost context for Mounjaro treatment if a longer course is being considered, and exploring all your options through a free consultation with our prescribers. If you're asking why Mounjaro is not working for you, or finding that tirzepatide is not working as expected, both are solvable questions that rarely mean the treatment has nothing left to offer. Speak to our prescribers about what the next step looks like for your specific situation.